Rapid susceptibility testing of medically important zygomycetes by XTT assay.
about
An antimicrobial peptidomimetic induces Mucorales cell death through mitochondria-mediated apoptosisRole of trehalose biosynthesis in Aspergillus fumigatus development, stress response, and virulenceApophysomyces elegans: epidemiology, amplified fragment length polymorphism typing, and in vitro antifungal susceptibility patternPotential antifungal effects of human platelets against zygomycetes in vitroDiagnosis and treatment of mucormycosis in patients with hematological malignancies: guidelines from the 3rd European Conference on Infections in Leukemia (ECIL 3).The characteristics of Aspergillus fumigatus mycetoma development: is this a biofilm?CotH3 mediates fungal invasion of host cells during mucormycosis.Mucormycosis in immunochallenged patients.Rhino-orbital-cerebral mucormycosis.Pseudomonas aeruginosa Inhibits the Growth of Scedosporium and Lomentospora In Vitro.Comparison between the standardized clinical and laboratory standards institute M38-A2 method and a 2,3-Bis(2-Methoxy-4-Nitro-5-[(Sulphenylamino)Carbonyl]-2H-tetrazolium hydroxide- based method for testing antifungal susceptibility of dermatophytes.Starvation survival of Candida albicans in various water microcosms.Early clinical and laboratory diagnosis of invasive pulmonary, extrapulmonary, and disseminated mucormycosis (zygomycosis).Aqueous extracts of Tulbaghia violacea inhibit germination of Aspergillus flavus and Aspergillus parasiticus conidia.Apoptotic-like phenotype triggered by hydrogen peroxide and amphotericin B in the fungus Rhizopus arrhizus.Tulbaghia violacea Harv. plant extract affects cell wall synthesis in Aspergillus flavus.A rapid microplate method for the proliferation assay of fungi and the antifungal susceptibility testing using the colorimetric microbial viability assay.
P2860
Q28534020-9DAC9FE3-58E9-48BF-8F30-88F78C7D99D9Q33963040-9668391B-A190-409F-A8DC-D0A8C4152FB8Q34433129-9B1C4851-A2E9-4F35-82D6-EE4D7DB1D4B2Q34475409-0CE1CDB9-0C92-4FE2-803A-5C239D3E8449Q36862446-0C4C7A0A-7099-488F-95D1-2AD472BDD3CCQ37226633-4283DA5C-3E02-49A4-AF42-63FFC00436F3Q37410618-D904BE98-E244-4C33-942C-234B5A0BAD6AQ37534298-6B5EDEA0-AAB7-4851-BEFA-D1AD82A9B271Q38017577-5CA58761-777C-4351-8DD3-45C67A5D041CQ40209634-5F2DF617-FC7C-4AF8-AC40-509240142E4CQ43116151-F423DD0B-BB05-4D0C-B3F2-0092B3A63BBAQ43528598-7A26FA85-B2A1-47C2-8A16-94CDF423F7E3Q45260992-7B9E4D49-0E0E-47B8-98FF-29288E2F2478Q46447421-7C97E84C-9F41-4218-87B1-A7A5B914E146Q46832295-0D0455B6-EE33-4F1E-8B65-42B940D397F4Q46890839-DC04914D-5430-438A-89D5-C6C250327A07Q50700721-63093CAF-EE23-46C1-B120-45642603F2E4
P2860
Rapid susceptibility testing of medically important zygomycetes by XTT assay.
description
2006 nî lūn-bûn
@nan
2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Rapid susceptibility testing of medically important zygomycetes by XTT assay.
@ast
Rapid susceptibility testing of medically important zygomycetes by XTT assay.
@en
Rapid susceptibility testing of medically important zygomycetes by XTT assay.
@nl
type
label
Rapid susceptibility testing of medically important zygomycetes by XTT assay.
@ast
Rapid susceptibility testing of medically important zygomycetes by XTT assay.
@en
Rapid susceptibility testing of medically important zygomycetes by XTT assay.
@nl
prefLabel
Rapid susceptibility testing of medically important zygomycetes by XTT assay.
@ast
Rapid susceptibility testing of medically important zygomycetes by XTT assay.
@en
Rapid susceptibility testing of medically important zygomycetes by XTT assay.
@nl
P2093
P2860
P1476
Rapid susceptibility testing of medically important zygomycetes by XTT assay.
@en
P2093
Charalampos Antachopoulos
Joseph Meletiadis
Thomas J Walsh
P2860
P304
P356
10.1128/JCM.44.2.553-560.2006
P407
P577
2006-02-01T00:00:00Z